Medpace Holdings, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
Medpace Holdings, Inc. announced robust financial results for fiscal year 2025, driven by significant revenue growth and continued strategic share repurchases.
NASDAQ
Medpace Holdings, Inc. announces a robust fiscal year 2024 with significant revenue growth and an increase in its stock repurchase program, signaling continued financial strength and commitment to shareholder value.
NASDAQ
Medpace Holdings, Inc. demonstrates robust growth in its 2023 annual report, marked by a significant increase in revenue and backlog.